Uterine Cancer

There are more than 63,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009. A book focusing on these cancers was timely, with emergent sophistication in diagnosis increasingly impacting clinical decision-making. However, five years later, the need for an updated book on this topic is even stronger as oncologists recognize opportunities to impact the outcome on women that are increasingly diagnosed with these malignancies. Uterine Cancer: Screening, Diagnosis, and Treatment, Second Edition, part of the Current Clinical Oncology series, enhances the awareness on this somewhat neglected area of therapeutics, helping to integrate targeted therapies into the management of women with uterine cancer. Written by experts in the field in a highly practical and comprehensive manner, it is a must-have for all gynecological residents and fellows, as well as gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors who wish to provide their patients with the best possible care.

Focuses on uterine and endometrial cancers and the impact oncologists can have on the outcome of women diagnosed with these malignancies Updated with new chapters on molecular classification of endometrial cancers and hormonal therapies Enhances the awareness of this somewhat neglected area of therapeutics Helps integrate targeted therapies into the management of women with uterine cancer Written by experts in the field in a highly practical and comprehensive manner Must-have for all gynecological residents and fellows, gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors

Autorentext

Dr. Franco Muggia is a Professor in the Department of Medicine at the Perlmutter Cancer Center at NYU Langone. His medical expertise include gynecologic cancers, breast cancer, and gynecologic oncology. Dr. Alessandro Santin is a Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. He is also the Clinical Research Program Leader in the Gynecologic Oncology Program at Yale Cancer Center. Dr. Esther Oliva is a Pathologist at Massachusetts General Hospital and a Professor of Pathology at Harvard Medical School.

Inhalt
The Essential Epidemiology of Cancer of the Endometrium.- Endometrial Cancer: Screening, Diagnosis, and Surgical Staging.- Imaging in the Diagnosis and Treatment of Endometrial Cancer.- Uterine Cancer: Pathology.- Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas.- Prognostic Factors in Uterine Cancer.- Primary Hormonal Therapy of Endometrial Cancer.- Early-Stage Endometrial Cancer: Surgery.- Early-Stage Endometrial Cancer: RadiationLess May Be More.- Therapeutic Modalities in Early-Stage Uterine Papillary Serous Carcinomas, Carcinosarcomas, Clear-Cell and Mixed Histology Carcinomas: Treatment of Choice Is Combined Chemotherapy and Radiation.- Treatment of Advanced and Recurrent Carcinoma: Chemotherapy.- Treatment for Advanced and Recurrent Carcinoma: Combined Modalities.- Management of Uterine Sarcomas.- Future Directions and New Targets in Endometrial Cancer.